Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 232 (7%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3280 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-VORICONAZOLE | 200MG | TABLET | Resolved | 2017-06-27 | 2017-08-15 | 14073 |
| APO-VORICONAZOLE | 200MG | TABLET | Resolved | 2018-07-11 | 2018-09-12 | 55293 |
| APO-VORICONAZOLE | 50MG | TABLET | Resolved | 2018-07-11 | 2018-09-12 | 55296 |
| APO-VORTIOXETINE | 10MG | TABLET | Resolved | 2025-07-10 | 2025-07-25 | 262442 |
| APO-VORTIOXETINE | 20MG | TABLET | Resolved | 2025-10-10 | 2025-10-31 | 269329 |
| APO-VORTIOXETINE | 10MG | TABLET | Resolved | 2025-10-10 | 2025-10-31 | 269338 |
| APO-WARFARIN | 4MG | TABLET | Resolved | 2017-03-12 | 2017-06-08 | 695 |
| APO-WARFARIN | 4MG | TABLET | Resolved | 2018-05-23 | 2018-07-03 | 50162 |
| APO-WARFARIN | 2.5MG | TABLET | Resolved | 2020-01-08 | 2020-06-08 | 102666 |
| APO-WARFARIN | 2.5MG | TABLET | Resolved | 2020-01-08 | 2020-06-08 | 102671 |
| APO-WARFARIN | 5MG | TABLET | Resolved | 2020-04-13 | 2020-05-28 | 111966 |
| APO-WARFARIN | 1MG | TABLET | Resolved | 2020-04-15 | 2020-05-11 | 112208 |
| APO-WARFARIN | 10MG | TABLET | Resolved | 2020-05-13 | 2020-06-22 | 114970 |
| APO-WARFARIN | 2MG | TABLET | Resolved | 2020-05-13 | 2020-07-28 | 114975 |
| APO-WARFARIN | 5MG | TABLET | Resolved | 2020-07-08 | 2020-09-21 | 119773 |
| APO-WARFARIN | 5MG | TABLET | Resolved | 2020-07-29 | 2020-09-21 | 121343 |
| APO-WARFARIN | 5MG | TABLET | Resolved | 2020-10-21 | 2020-12-28 | 126780 |
| APO-WARFARIN | 1MG | TABLET | Resolved | 2023-11-17 | 2023-12-22 | 210698 |
| APO-WARFARIN | 1MG | TABLET | Resolved | 2024-04-05 | 2024-05-15 | 224589 |
| APO-WARFARIN | 1MG | TABLET | Resolved | 2024-04-19 | 2024-05-15 | 225782 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |